{"id":62543,"date":"2026-01-26T22:06:07","date_gmt":"2026-01-26T21:06:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/"},"modified":"2026-01-26T22:06:07","modified_gmt":"2026-01-26T21:06:07","slug":"definium-therapeutics-announces-new-employee-inducement-grants","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/","title":{"rendered":"Definium Therapeutics Announces New Employee Inducement Grants"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. <\/strong>(formerly Mind Medicine (MindMed) Inc.)<\/b> (\u201cDefinium\u201d or the \u201cCompany\u201d), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 88,850 common shares of the Company (the “Options”) with effective grant dates of January 12 and January 26, 2025. The Options have an exercise price equal to the closing price of Definium\u2019s common shares on the date of the respective grant, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in substantially equal monthly increments over the three-year period thereafter, subject to each employee\u2019s continued employment.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Options were granted as a material inducement to each employee\u2019s employment and were approved by Definium’s Compensation Committee on January 8, 2026, in accordance with Rule 5635(c)(4) of The NASDAQ Stock Market LLC. The Options were granted outside Definium’s equity incentive plans.<\/p>\n

\nAbout Definium Therapeutics<\/b><\/p>\n

\nThe mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today\u2019s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.<\/p>\n

\nFor more information, visit https:\/\/definiumtx.com\/<\/a> and follow Definium Therapeutics on Instagram<\/a>, LinkedIn<\/a> and X<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Gitanjali Jain
\n
VP, Head of Investor Relations
\n
ir@definiumtx.com<\/a><\/p>\n

\nMedia Contact:<\/b>
media@definiumtx.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (\u201cDefinium\u201d or the \u201cCompany\u201d), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62543","6":"format-standard","7":"category-industry"},"yoast_head":"\nDefinium Therapeutics Announces New Employee Inducement Grants - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Definium Therapeutics Announces New Employee Inducement Grants - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (\u201cDefinium\u201d or the \u201cCompany\u201d), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-26T21:06:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Definium Therapeutics Announces New Employee Inducement Grants\",\"datePublished\":\"2026-01-26T21:06:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/\"},\"wordCount\":320,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260126110151\\\/en\\\/2701261\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/\",\"name\":\"Definium Therapeutics Announces New Employee Inducement Grants - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260126110151\\\/en\\\/2701261\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"datePublished\":\"2026-01-26T21:06:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260126110151\\\/en\\\/2701261\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260126110151\\\/en\\\/2701261\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-announces-new-employee-inducement-grants\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Definium Therapeutics Announces New Employee Inducement Grants\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Definium Therapeutics Announces New Employee Inducement Grants - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/","og_locale":"en_US","og_type":"article","og_title":"Definium Therapeutics Announces New Employee Inducement Grants - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (\u201cDefinium\u201d or the \u201cCompany\u201d), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-26T21:06:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Definium Therapeutics Announces New Employee Inducement Grants","datePublished":"2026-01-26T21:06:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/"},"wordCount":320,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/","url":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/","name":"Definium Therapeutics Announces New Employee Inducement Grants - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","datePublished":"2026-01-26T21:06:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260126110151\/en\/2701261\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-announces-new-employee-inducement-grants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Definium Therapeutics Announces New Employee Inducement Grants"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62543"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62543\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}